Income Statement CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2025-12-15 pm EST			5-day change	1st Jan Change
79.69 ^USD	+0.34%		+4.13%	+77.52%

Dec. 12	Bernstein Adjusts CVS Health Price Target to $87 From $86, Maintains Market Perform Rating	MT
Dec. 11	Cvs Health offers measles vaccine to South Carolina residents amid state's current outbreak	RE

ee346.RCSNEjxEb40PF0LXiXcNwdF9sKjzIGnpZGW3V5pVXMs.MX7-Y3JwW8dnZArk7R5Jtaks8p2JZ1m5VgfAJtYHFJ0FRu9ocSgw50tTIQ

Published financial data: CVS HEALTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	268B	291B	322B	357B	371B
Total Revenues	268B	291B	322B	357B	371B
Cost of Goods Sold, Total	220B	240B	268B	303B	321B
Gross Profit	48.25B	50.85B	53.46B	53.28B	49.25B
Selling General & Admin Expenses, Total	34.58B	37.07B	38.04B	39.2B	41.23B
Other Operating Expenses, Total	34.58B	37.07B	38.04B	39.2B	41.23B
Operating Income	13.66B	13.78B	15.42B	14.07B	8.02B
Interest Expense, Total	-2.91B	-2.5B	-2.29B	-2.66B	-2.96B
Interest And Investment Income	798M	1.2B	838M	1.15B	2.15B
Net Interest Expenses	-2.11B	-1.3B	-1.45B	-1.5B	-805M
Other Non Operating Income (Expenses)	-12M	-4M	-4M	-6M	-5M
EBT, Excl. Unusual Items	11.54B	12.47B	13.96B	12.56B	7.21B
Restructuring Charges	-	-1.36B	-	-553M	-1.21B
Merger & Related Restructuring Charges	-332M	-132M	-	-487M	-243M
Impairment of Goodwill	-	-431M	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-2.53B	-349M	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	263M	-5.8B	-	-100M
Other Unusual Items	-1.44B	-391M	-	-	491M
EBT, Incl. Unusual Items	9.77B	10.42B	5.63B	11.17B	6.15B
Income Tax Expense	2.57B	2.52B	1.46B	2.8B	1.56B
Earnings From Continuing Operations	7.2B	7.9B	4.16B	8.37B	4.59B
Earnings Of Discontinued Operations	-9M	-	-	-	-
Net Income to Company	7.19B	7.9B	4.16B	8.37B	4.59B
Minority Interest	-13M	12M	-16M	-24M	28M
Net Income - (IS)	7.18B	7.91B	4.15B	8.34B	4.61B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	7.18B	7.91B	4.15B	8.34B	4.61B
Net Income to Common Excl. Extra Items	7.19B	7.91B	4.15B	8.34B	4.61B
Per Share Items
Net EPS - Basic	5.48	6	3.16	6.49	3.66
Basic EPS - Continuing Operations	5.49	6	3.16	6.49	3.66
Basic Weighted Average Shares Outstanding	1.31B	1.32B	1.31B	1.28B	1.26B
Net EPS - Diluted	5.46	5.95	3.14	6.47	3.66
Diluted EPS - Continuing Operations	5.47	5.95	3.14	6.47	3.66
Diluted Weighted Average Shares Outstanding	1.31B	1.33B	1.32B	1.29B	1.26B
Normalized Basic EPS	5.5	5.92	6.64	6.09	3.6
Normalized Diluted EPS	5.48	5.87	6.58	6.07	3.59
Dividend Per Share	2	2	2.2	2.42	2.66
Payout Ratio	36.55	33.19	70.06	37.54	73.1
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	18.1B	18.29B	19.66B	18.44B	12.62B
EBITA	16B	16.04B	17.22B	15.98B	10.04B
EBIT	13.66B	13.78B	15.42B	14.07B	8.02B
EBITDAR	21.34B	21.5B	22.82B	21.56B	15.64B
Total Revenues (As Reported)	269B	292B	322B	358B	373B
Effective Tax Rate - (Ratio)	26.29	24.2	26	25.11	25.41
Current Domestic Taxes	3.13B	2.95B	3.54B	3.48B	2.13B
Total Current Taxes	3.13B	2.95B	3.54B	3.48B	2.13B
Deferred Domestic Taxes	-564M	-428M	-2.08B	-676M	-572M
Total Deferred Taxes	-564M	-428M	-2.08B	-676M	-572M
Normalized Net Income	7.2B	7.81B	8.71B	7.83B	4.53B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	3B	2.54B	2.29B	73M	71M
Non-Cash Pension Expense	-218M	-186M	-173M	-94M	-104M
Supplemental Operating Expense Items
Advertising Expense	461M	523M	745M	985M	989M
Selling and Marketing Expenses	461M	523M	745M	985M	989M
Net Rental Expense, Total	3.24B	3.21B	3.16B	3.13B	3.02B
Imputed Operating Lease Interest Expense	865M	798M	787M	886M	882M
Imputed Operating Lease Depreciation	2.37B	2.41B	2.37B	2.24B	2.14B
Stock-Based Comp., Other (Total)	400M	484M	447M	588M	540M
Total Stock-Based Compensation	400M	484M	447M	588M	540M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	7.85B	9.41B	12.94B	8.2B	8.59B
Short Term Investments	3B	3.12B	2.78B	3.26B	2.41B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	10.85B	12.52B	15.72B	11.46B	10.99B
Accounts Receivable, Total	19.54B	21.04B	23.83B	15.62B	14.61B
Other Receivables	2.2B	3.39B	3.45B	19.6B	21.86B
Total Receivables	21.74B	24.43B	27.28B	35.23B	36.47B
Inventory	18.5B	17.76B	19.09B	18.02B	18.11B
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	3.06B	144M	90M	95M
Other Current Assets, Total	5.28B	2.23B	3.45B	3.06B	2.98B
Total Current Assets	56.37B	60.01B	65.68B	67.86B	68.64B
Gross Property Plant And Equipment	52.04B	52.67B	52.23B	51.13B	52.38B
Accumulated Depreciation	-18.7B	-20.65B	-21.48B	-20.7B	-23.45B
Net Property Plant And Equipment	33.34B	32.02B	30.74B	30.44B	28.94B
Long-term Investments	20.81B	23.02B	21.1B	23.02B	28.93B
Goodwill	79.55B	79.12B	78.15B	91.27B	91.27B
Other Intangibles, Total	31.14B	29.03B	24.75B	29.23B	27.32B
Other Long-Term Assets, Total	9.5B	9.8B	7.85B	7.91B	8.1B
Total Assets	231B	233B	228B	250B	253B
Liabilities
Accounts Payable, Total	11.14B	12.54B	14.84B	14.9B	15.89B
Accrued Expenses, Total	22.03B	25.29B	29.08B	33.94B	35.73B
Short-term Borrowings	-	-	-	200M	2.12B
Current Portion of Long-Term Debt	5.41B	4.16B	1.72B	2.71B	3.56B
Current Portion of Leases	1.67B	1.7B	1.74B	1.81B	1.82B
Unearned Revenue Current, Total	71M	87M	71M	149M	144M
Other Current Liabilities	21.7B	24.03B	22.29B	25.49B	25.35B
Total Current Liabilities	62.02B	67.81B	69.74B	79.19B	84.61B
Long-Term Debt	58.16B	50.72B	49.07B	57.31B	59.23B
Long-Term Leases	19.81B	19.43B	18.21B	17.36B	16.19B
Pension & Other Post Retirement Benefits	285M	250M	197M	189M	169M
Deferred Tax Liability Non Current	6.79B	6.27B	3.88B	4.31B	3.81B
Other Non Current Liabilities	13.95B	13.14B	15.87B	14.73B	13.48B
Total Liabilities	161B	158B	157B	173B	177B
Common Stock, Total	17M	17M	18M	18M	18M
Additional Paid In Capital	46.5B	47.36B	48.18B	48.97B	49.64B
Retained Earnings	49.64B	54.91B	56.14B	61.6B	62.84B
Treasury Stock	-28.15B	-28.14B	-31.83B	-33.81B	-36.82B
Comprehensive Income and Other	1.38B	936M	-1.49B	-326M	-120M
Total Common Equity	69.39B	75.08B	71.02B	76.46B	75.56B
Minority Interest	312M	306M	300M	175M	170M
Total Equity	69.7B	75.38B	71.32B	76.64B	75.73B
Total Liabilities And Equity	231B	233B	228B	250B	253B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.31B	1.31B	1.28B	1.26B	1.26B
ECS Total Common Shares Outstanding	1.31B	1.32B	1.3B	1.29B	1.26B
Book Value / Share	52.97	56.79	54.63	59.36	59.97
Tangible Book Value	-41.3B	-33.07B	-31.89B	-44.04B	-43.04B
Tangible Book Value Per Share	-31.53	-25.02	-24.53	-34.2	-34.15
Total Debt	85.04B	76B	70.73B	79.38B	82.92B
Net Debt	74.19B	63.47B	55.01B	67.93B	71.93B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-383M	-668M	-606M	-643M	-839M
Debt Equivalent Oper. Leases	25.89B	25.66B	25.24B	25.01B	24.19B
Minority Interest, Total (Incl. Fin. Div)	312M	306M	300M	175M	170M
Account Code - Inventory Valuation	6	6	6	6	6
Land - (BS)	2.13B	2.04B	2B	1.96B	1.85B
Buildings, Total	3.95B	4.22B	4.54B	4.57B	4.63B
Machinery, Total	13.12B	13.62B	12.73B	11.02B	11.72B
Full Time Employees	213K	216K	219K	219K	219K
Part Time Employees	87K	84K	81K	81K	81K
Accumulated Allowance for Doubtful Accounts (Supple)	358M	339M	333M	343M	407M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	7.18B	7.91B	4.15B	8.34B	4.61B
Depreciation & Amortization - CF	2.1B	2.25B	2.44B	2.46B	2.57B
Amortization of Goodwill and Intangible Assets - (CF)	2.34B	2.26B	1.81B	1.9B	2.02B
Depreciation & Amortization, Total	4.44B	4.51B	4.25B	4.37B	4.6B
(Gain) Loss From Sale Of Asset	-269M	-	2.06B	349M	-
Asset Writedown & Restructuring Costs	-	1.79B	-	-	840M
Stock-Based Compensation (CF)	400M	484M	447M	588M	540M
Other Operating Activities, Total	955M	-378M	-1.73B	-236M	-1.59B
Change In Accounts Receivable	-1.51B	-2.7B	-2.97B	-6.26B	-1.3B
Change In Inventories	-973M	735M	-1.44B	1.23B	-102M
Change In Accounts Payable	2.77B	2.9B	4.26B	3.62B	2.34B
Change in Other Net Operating Assets	2.87B	3.02B	7.15B	1.42B	-823M
Cash from Operations	15.86B	18.26B	16.18B	13.43B	9.11B
Capital Expenditure	-2.44B	-2.52B	-2.73B	-3.03B	-2.78B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-866M	-146M	-139M	-16.61B	-95M
Divestitures	840M	-	-1.25B	-	-
Investment in Marketable and Equity Securities, Total	-3.17B	-2.72B	-1.02B	-1.31B	-4.84B
Other Investing Activities, Total	101M	122M	85M	68M	101M
Cash from Investing	-5.53B	-5.26B	-5.05B	-20.89B	-7.61B
Short Term Debt Issued, Total	-	-	-	5.2B	1.92B
Long-Term Debt Issued, Total	9.96B	987M	-	10.9B	7.91B
Total Debt Issued	9.96B	987M	-	16.1B	9.83B
Short Term Debt Repaid, Total	-	-	-	-5B	-
Long-Term Debt Repaid, Total	-15.63B	-10.25B	-4.21B	-3.17B	-4.77B
Total Debt Repaid	-15.63B	-10.25B	-4.21B	-8.17B	-4.77B
Issuance of Common Stock	264M	549M	551M	277M	361M
Repurchase of Common Stock	-88M	-168M	-3.87B	-2.19B	-3.21B
Common Dividends Paid	-2.62B	-2.62B	-2.91B	-3.13B	-3.37B
Common & Preferred Stock Dividends Paid	-2.62B	-2.62B	-2.91B	-3.13B	-3.37B
Other Financing Activities, Total	-34M	155M	-79M	-201M	26M
Cash from Financing	-8.16B	-11.36B	-10.52B	2.68B	-1.14B
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	2.18B	1.65B	614M	-4.78B	359M
Supplemental Items
Cash Interest Paid	2.9B	2.47B	2.24B	2.42B	2.91B
Cash Income Tax Paid (Refund)	2.93B	3.2B	4.12B	3.52B	1.7B
Levered Free Cash Flow	12.87B	14.57B	12.02B	11.08B	6.91B
Unlevered Free Cash Flow	14.69B	16.14B	13.45B	12.74B	8.76B
Change In Net Working Capital	-3.74B	-5.05B	-1.85B	-2.02B	-1.39B
Net Debt Issued / Repaid	-5.67B	-9.27B	-4.21B	7.93B	5.06B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.77	3.71	4.18	3.68	1.99
Return on Total Capital	5.55	5.63	6.57	5.89	3.19
Return On Equity %	10.76	10.89	5.68	11.28	6.02
Return on Common Equity	10.79	10.95	5.68	11.28	6.07
Margin Analysis
Gross Profit Margin %	18.01	17.48	16.62	14.94	13.29
SG&A Margin	12.91	12.74	11.83	10.99	11.12
EBITDA Margin %	6.76	6.29	6.11	5.17	3.4
EBITA Margin %	5.97	5.51	5.36	4.48	2.71
EBIT Margin %	5.1	4.74	4.79	3.95	2.16
Income From Continuing Operations Margin %	2.69	2.71	1.29	2.35	1.24
Net Income Margin %	2.68	2.72	1.29	2.34	1.24
Net Avail. For Common Margin %	2.68	2.72	1.29	2.34	1.24
Normalized Net Income Margin	2.69	2.68	2.71	2.19	1.22
Levered Free Cash Flow Margin	4.8	5.01	3.74	3.11	1.86
Unlevered Free Cash Flow Margin	5.48	5.55	4.18	3.57	2.36
Asset Turnover
Asset Turnover	1.18	1.25	1.39	1.49	1.47
Fixed Assets Turnover	8.09	8.9	10.25	11.66	12.49
Receivables Turnover (Average Receivables)	14.57	14.34	14.34	16.63	24.52
Inventory Turnover (Average Inventory)	12.2	13.24	14.55	16.35	17.79
Short Term Liquidity
Current Ratio	0.91	0.88	0.94	0.86	0.81
Quick Ratio	0.53	0.55	0.62	0.59	0.56
Operating Cash Flow to Current Liabilities	0.26	0.27	0.23	0.17	0.11
Days Sales Outstanding (Average Receivables)	25.12	25.46	25.46	21.95	14.93
Days Outstanding Inventory (Average Inventory)	30	27.56	25.08	22.33	20.57
Average Days Payable Outstanding	17.94	18.06	18.54	17.95	17.53
Cash Conversion Cycle (Average Days)	37.18	34.96	31.99	26.33	17.97
Long Term Solvency
Total Debt/Equity	122.01	100.82	99.18	103.59	109.49
Total Debt / Total Capital	54.96	50.2	49.79	50.88	52.27
LT Debt/Equity	111.85	93.06	94.34	97.44	99.6
Long-Term Debt / Total Capital	50.38	46.34	47.36	47.86	47.54
Total Liabilities / Total Assets	69.79	67.65	68.76	69.31	70.09
EBIT / Interest Expense	4.7	5.5	6.74	5.29	2.71
EBITDA / Interest Expense	7.34	8.59	9.98	8.11	5.29
(EBITDA - Capex) / Interest Expense	6.5	7.58	8.79	6.97	4.35
Total Debt / EBITDA	3.99	3.54	3.1	3.68	5.3
Net Debt / EBITDA	3.48	2.95	2.41	3.15	4.6
Total Debt / (EBITDA - Capex)	4.5	4.01	3.52	4.28	6.45
Net Debt / (EBITDA - Capex)	3.92	3.34	2.74	3.67	5.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.75	8.59	10.56	10.88	3.93
Gross Profit, 1 Yr. Growth %	8.38	5.39	5.13	-0.72	-7.56
EBITDA, 1 Yr. Growth %	11.83	1.02	5.99	-7.65	-31.58
EBITA, 1 Yr. Growth %	12.28	0.2	5.68	-8.84	-37.14
EBIT, 1 Yr. Growth %	15.61	0.83	9.81	-10.6	-43.02
Earnings From Cont. Operations, 1 Yr. Growth %	8.6	9.68	-47.27	93.39	-45.2
Net Income, 1 Yr. Growth %	8.22	10.18	-47.55	93.55	-44.7
Normalized Net Income, 1 Yr. Growth %	17.66	8.39	9.31	-12.2	-42.08
Diluted EPS Before Extra, 1 Yr. Growth %	7.68	8.78	-47.23	98.47	-43.43
Accounts Receivable, 1 Yr. Growth %	13.39	7.66	13.24	-42.73	-6.47
Inventory, 1 Yr. Growth %	5.59	-3.98	7.49	-5.58	0.45
Net Property, Plant and Equip., 1 Yr. Growth %	1.31	-3.95	-3.98	-1.01	-4.92
Total Assets, 1 Yr. Growth %	3.72	0.99	-2.03	9.4	1.4
Tangible Book Value, 1 Yr. Growth %	-15.71	-19.93	-3.58	39.9	-2.29
Common Equity, 1 Yr. Growth %	8.65	8.19	-5.41	6.98	-1.18
Cash From Operations, 1 Yr. Growth %	23.48	15.13	-11.43	-17.01	-32.17
Capital Expenditures, 1 Yr. Growth %	-0.81	3.41	8.21	11.15	-8.25
Levered Free Cash Flow, 1 Yr. Growth %	26.5	13.21	-18.42	-7.21	-37.62
Unlevered Free Cash Flow, 1 Yr. Growth %	21.67	9.86	-17.48	-4.7	-31.24
Dividend Per Share, 1 Yr. Growth %	0	0	10	10	9.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.54	6.65	9.57	10.72	7.35
Gross Profit, 2 Yr. CAGR %	25	6.88	5.26	2.29	-4.2
EBITDA, 2 Yr. CAGR %	19.07	6.29	4.22	-0.55	-20.51
EBITA, 2 Yr. CAGR %	20.31	6.07	3.74	-1.26	-24.3
EBIT, 2 Yr. CAGR %	16.59	7.97	6.22	-0.3	-28.63
Earnings From Cont. Operations, 2 Yr. CAGR %	247.59	9.14	-23.95	2.34	2.95
Net Income, 2 Yr. CAGR %	247.65	9.19	-23.98	2.12	3.45
Normalized Net Income, 2 Yr. CAGR %	19.31	12.93	9.99	-1.35	-28.69
Diluted EPS Before Extra, 2 Yr. CAGR %	209.28	8.22	-24.23	3.67	5.96
Accounts Receivable, 2 Yr. CAGR %	10.28	10.49	10.41	-13.84	-26.81
Inventory, 2 Yr. CAGR %	6.04	0.69	1.59	0.74	-2.61
Net Property, Plant and Equip., 2 Yr. CAGR %	71.38	-1.36	-3.96	-2.5	-2.98
Total Assets, 2 Yr. CAGR %	8.37	2.34	-0.53	3.53	5.32
Tangible Book Value, 2 Yr. CAGR %	-14.86	-17.85	-12.13	15.4	16.91
Common Equity, 2 Yr. CAGR %	9.17	8.42	1.16	0.92	2.82
Cash From Operations, 2 Yr. CAGR %	33.78	19.23	0.98	-14.26	-24.97
Capital Expenditures, 2 Yr. CAGR %	9.38	1.27	5.78	9.67	0.99
Levered Free Cash Flow, 2 Yr. CAGR %	1.14	19.67	-3.36	-13.44	-23.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	1.64	15.62	-4.3	-11.73	-19.05
Dividend Per Share, 2 Yr. CAGR %	0	0	4.88	10	9.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.18	14.48	7.94	10	8.41
Gross Profit, 3 Yr. CAGR %	19.17	18.09	6.29	3.36	-1.11
EBITDA, 3 Yr. CAGR %	13.91	12.72	6.7	0.61	-12.21
EBITA, 3 Yr. CAGR %	14.77	13.19	6.51	-0.05	-15.06
EBIT, 3 Yr. CAGR %	11.83	11.08	9.27	0.99	-17.26
Earnings From Cont. Operations, 3 Yr. CAGR %	2.79	136.64	-14.36	5.13	-16.89
Net Income, 3 Yr. CAGR %	2.73	137.03	-14.48	5.14	-16.76
Normalized Net Income, 3 Yr. CAGR %	9.7	15.56	12.49	2.82	-17.39
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.35	118.31	-14.82	5.76	-15.28
Accounts Receivable, 3 Yr. CAGR %	14.45	9.4	11.4	-7.19	-11.45
Inventory, 3 Yr. CAGR %	6.54	2.59	2.91	-0.86	0.65
Net Property, Plant and Equip., 3 Yr. CAGR %	47.96	41.3	-2.24	-2.99	-3.32
Total Assets, 3 Yr. CAGR %	34.35	5.85	0.87	2.67	2.81
Tangible Book Value, 3 Yr. CAGR %	42.12	-16.58	-13.34	2.16	9.17
Common Equity, 3 Yr. CAGR %	22.56	8.84	3.6	3.29	0.21
Cash From Operations, 3 Yr. CAGR %	25.6	27.25	7.98	-5.41	-20.7
Capital Expenditures, 3 Yr. CAGR %	8.31	7.35	3.54	7.54	3.34
Levered Free Cash Flow, 3 Yr. CAGR %	29.88	5.02	5.72	-4.88	-22.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	30.97	4.31	3.67	-4.64	-18.78
Dividend Per Share, 3 Yr. CAGR %	0	0	3.23	6.56	9.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.81	10.38	11.72	12.96	7.7
Gross Profit, 5 Yr. CAGR %	12.71	11.99	13.4	11.53	2.04
EBITDA, 5 Yr. CAGR %	8.96	6.98	9.93	7.63	-4.86
EBITA, 5 Yr. CAGR %	9.2	7.12	10.22	7.64	-6.76
EBIT, 5 Yr. CAGR %	7.1	5.43	9.55	6.96	-7.46
Earnings From Cont. Operations, 5 Yr. CAGR %	6.61	8.22	-8.88	69.62	-7.11
Net Income, 5 Yr. CAGR %	6.51	8.27	-8.93	69.64	-7
Normalized Net Income, 5 Yr. CAGR %	5.33	5.59	9.82	9.12	-5.82
Diluted EPS Before Extra, 5 Yr. CAGR %	3.44	3.92	-13.41	62.45	-6.35
Accounts Receivable, 5 Yr. CAGR %	10.45	11.58	12.82	-0.57	-3.25
Inventory, 5 Yr. CAGR %	5.73	3.77	4.53	1.85	0.67
Net Property, Plant and Equip., 5 Yr. CAGR %	27.6	25.77	24.47	21.81	-2.54
Total Assets, 5 Yr. CAGR %	20.07	19.79	19.13	4.92	2.62
Tangible Book Value, 5 Yr. CAGR %	22.81	17.24	17.25	-5.02	-2.57
Common Equity, 5 Yr. CAGR %	13.28	15.31	13.51	5.6	3.42
Cash From Operations, 5 Yr. CAGR %	13.19	12.49	15.1	8.66	-6.65
Capital Expenditures, 5 Yr. CAGR %	0.58	2.53	7.29	8.27	2.51
Levered Free Cash Flow, 5 Yr. CAGR %	14.39	13.32	15.4	-2.52	-7.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.72	13.75	15.52	-2.18	-6.22
Dividend Per Share, 5 Yr. CAGR %	7.39	3.3	1.92	3.89	5.87